Working Group Chair: Charles Bowden, MD

Group will review recent publications on mitochondrial systems in CNS disorders, then address systematically by disease area potential mitochondria associated biological systems that could be targeted for development of new therapies.  This second focus, which links to specific ISCTM goals, will also include currently available drugs with actions in mitochondria.